Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

VISUDYNE

VERTEPORFIN

Standard Dose
15MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview VISUDYNE is listed in Drugs@FDA under application 021119 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient VERTEPORFIN Form and strength INJECTABLE;INJECTION - 15MG/VIAL Sponsor BAUSCH LOMB IRELAND Submission history Latest submission status date: 2023-02-12 00:00:00.

Structured Monograph

Clinical summary

Approval overview VISUDYNE is listed in Drugs@FDA under application 021119 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient VERTEPORFIN Form and strength INJECTABLE;INJECTION - 15MG/VIAL Sponsor BAUSCH LOMB IRELAND Submission history Latest submission status date: 2023-02-12 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.